Abstract
Recent genomic analyses of metastatic prostate cancer have provided important insight into adaptive changes in androgen receptor (AR) signaling that underpin resistance to androgen deprivation therapies. Novel strategies are required to circumvent these AR-mediated resistance mechanisms and thereby improve prostate cancer survival. In this review, we present a summary of AR structure and function and discuss mechanisms of AR-mediated therapy resistance that represent important areas of focus for the development of new therapies.
Original language | English |
---|---|
Article number | a030478 |
Journal | Cold Spring Harbor perspectives in medicine |
Volume | 8 |
Issue number | 12 |
Early online date | 12 Mar 2018 |
DOIs | |
Publication status | Published - 3 Dec 2018 |
Externally published | Yes |
Keywords
- prostate cancer
- Androgen Receptor